BDX Q3 2024 Earnings — Becton, Dickinson and Company Revenue & Financial Results | Market Cap Arena

BDXBecton, Dickinson and Company

$60B

Q3 2024 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$5.0B+2.3% YoY

Gross Profit

$2.3B46.2% margin

Operating Income

$602M12.1% margin

Net Income

$487M9.8% margin

EPS (Diluted)

$1.68

QoQ Revenue Growth

-1.1%

Cash Flow

Operating Cash Flow

$1.3B

Free Cash Flow

$1.1B

Stock-Based Comp.

$53M

Balance Sheet

Total Assets

$55.6B

Total Liabilities

$29.7B

Stockholders' Equity

$25.9B

Cash & Equivalents

$4.5B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5.0B	$4.9B	+2.3%
Gross Profit	$2.3B	$2.1B	+9.9%
Operating Income	$602M	$549M	+9.7%
Net Income	$487M	$407M	+19.7%

Revenue Segments

Medical

$2.6B51%

Life Sciences

$1.3B25%

Interventional

$1.2B25%

Geographic Segments

UNITED STATES

$2.9B58%

Non-US

$2.1B42%